Organogenesis Holdings
ORGO
149 hedge funds and large institutions have $149M invested in Organogenesis Holdings in 2022 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 53 increasing their positions, 49 reducing their positions, and 26 closing their positions.
61% more call options, than puts
Call options by funds: $61K | Put options by funds: $38K
8% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 49
0.33% more ownership
Funds ownership: 42.03% → 42.36% (+0.33%)
8% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 26
3% less funds holding
Funds holding: 154 → 149 (-5)
16% less capital invested
Capital invested by funds: $178M → $149M (-$29.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.63M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$2.55M |
| 3 |
BlackRock
New York
|
+$1.65M |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.27M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$3.71M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.66M |
| 3 |
HLA
Hamilton Lane Advisors
Conshohocken,
Pennsylvania
|
-$1.45M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.32M |
| 5 |
Two Sigma Advisers
New York
|
-$1.23M |
ORGO Hedge Fund Activity: Q4 2022 in Review
149 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q4 2022, worth a combined $149M — down 16% from $178M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of ORGO and 24 opened new positions — a net loss of 2 holders — while 49 trimmed existing stakes and 53 added.
The largest buyer was AQR Capital Management, adding an estimated $2.63M. The largest seller was Morgan Stanley, cutting an estimated $3.71M.
- 149 institutional investors held Organogenesis Holdings (ORGO) as of Q4 2022, down from 154 in Q3 2022.
- Funds reported $149M of Organogenesis Holdings stock for Q4 2022, down 16% quarter-over-quarter.
- 24 funds opened new Organogenesis Holdings positions in Q4 2022 and 26 closed out, a net change of -2 holders.
- The largest Organogenesis Holdings buyer in Q4 2022 was AQR Capital Management, an estimated $2.63M added.
- The largest Organogenesis Holdings seller in Q4 2022 was Morgan Stanley, an estimated $3.71M sold.
Based on aggregated 13F filings for Q4 2022.